Logo image of CTRN

CITI TRENDS INC (CTRN) Stock Fundamental Analysis

NASDAQ:CTRN - Nasdaq - US17306X1028 - Common Stock - Currency: USD

25.41  -1.3 (-4.87%)

After market: 25.41 0 (0%)

Fundamental Rating

3

Taking everything into account, CTRN scores 3 out of 10 in our fundamental rating. CTRN was compared to 120 industry peers in the Specialty Retail industry. The financial health of CTRN is average, but there are quite some concerns on its profitability. CTRN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year CTRN has reported negative net income.
In the past year CTRN has reported a negative cash flow from operations.
Of the past 5 years CTRN 4 years were profitable.
CTRN had a positive operating cash flow in 4 of the past 5 years.
CTRN Yearly Net Income VS EBIT VS OCF VS FCFCTRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M

1.2 Ratios

With a Return On Assets value of -5.45%, CTRN is not doing good in the industry: 70.09% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -19.53%, CTRN is doing worse than 63.25% of the companies in the same industry.
Industry RankSector Rank
ROA -5.45%
ROE -19.53%
ROIC N/A
ROA(3y)7.21%
ROA(5y)6.02%
ROE(3y)27.13%
ROE(5y)21.14%
ROIC(3y)N/A
ROIC(5y)N/A
CTRN Yearly ROA, ROE, ROICCTRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

With a Gross Margin value of 37.30%, CTRN perfoms like the industry average, outperforming 53.85% of the companies in the same industry.
CTRN's Gross Margin has been stable in the last couple of years.
CTRN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.42%
GM growth 5Y0.01%
CTRN Yearly Profit, Operating, Gross MarginsCTRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

5

2. Health

2.1 Basic Checks

CTRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CTRN has more shares outstanding
Compared to 5 years ago, CTRN has less shares outstanding
CTRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CTRN Yearly Shares OutstandingCTRN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CTRN Yearly Total Debt VS Total AssetsCTRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 2.72 indicates that CTRN is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.72, CTRN perfoms like the industry average, outperforming 58.97% of the companies in the same industry.
There is no outstanding debt for CTRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.72
ROIC/WACCN/A
WACC10.27%
CTRN Yearly LT Debt VS Equity VS FCFCTRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

CTRN has a Current Ratio of 1.15. This is a normal value and indicates that CTRN is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.15, CTRN is not doing good in the industry: 68.38% of the companies in the same industry are doing better.
A Quick Ratio of 0.35 indicates that CTRN may have some problems paying its short term obligations.
With a Quick ratio value of 0.35, CTRN is not doing good in the industry: 64.96% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.15
Quick Ratio 0.35
CTRN Yearly Current Assets VS Current LiabilitesCTRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for CTRN have decreased strongly by -153.54% in the last year.
Looking at the last year, CTRN shows a small growth in Revenue. The Revenue has grown by 1.99% in the last year.
Measured over the past years, CTRN shows a decrease in Revenue. The Revenue has been decreasing by -0.57% on average per year.
EPS 1Y (TTM)-153.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-39.29%
Revenue 1Y (TTM)1.99%
Revenue growth 3Y-1.53%
Revenue growth 5Y-0.57%
Sales Q2Q%-0.25%

3.2 Future

The Earnings Per Share is expected to grow by 36.30% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 4.63% on average over the next years.
EPS Next Y-127.33%
EPS Next 2Y22.23%
EPS Next 3Y29.39%
EPS Next 5Y36.3%
Revenue Next Year0.33%
Revenue Next 2Y2.03%
Revenue Next 3Y2.86%
Revenue Next 5Y4.63%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CTRN Yearly Revenue VS EstimatesCTRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
CTRN Yearly EPS VS EstimatesCTRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

CTRN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CTRN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CTRN Price Earnings VS Forward Price EarningsCTRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CTRN Per share dataCTRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

CTRN's earnings are expected to grow with 29.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.23%
EPS Next 3Y29.39%

More info and screens

0

5. Dividend

5.1 Amount

CTRN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CITI TRENDS INC

NASDAQ:CTRN (2/21/2025, 8:11:16 PM)

After market: 25.41 0 (0%)

25.41

-1.3 (-4.87%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)12-03 2024-12-03/bmo
Earnings (Next)06-02 2025-06-02/bmo
Inst Owners95.36%
Inst Owner Change-3.6%
Ins Owners11.14%
Ins Owner Change25.58%
Market Cap221.32M
Analysts80
Price Target33.15 (30.46%)
Short Float %9.88%
Short Ratio8.27
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.08
Dividend Growth(5Y)-8.11%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-139.65%
Min EPS beat(2)-263.43%
Max EPS beat(2)-15.86%
EPS beat(4)0
Avg EPS beat(4)-78.52%
Min EPS beat(4)-263.43%
Max EPS beat(4)-0.13%
EPS beat(8)2
Avg EPS beat(8)-76.31%
EPS beat(12)5
Avg EPS beat(12)-40.79%
EPS beat(16)9
Avg EPS beat(16)-7%
Revenue beat(2)0
Avg Revenue beat(2)-3.02%
Min Revenue beat(2)-3.37%
Max Revenue beat(2)-2.67%
Revenue beat(4)0
Avg Revenue beat(4)-2.71%
Min Revenue beat(4)-3.37%
Max Revenue beat(4)-2.33%
Revenue beat(8)1
Avg Revenue beat(8)-2.21%
Revenue beat(12)3
Avg Revenue beat(12)-2.42%
Revenue beat(16)5
Avg Revenue beat(16)-1.8%
PT rev (1m)1.2%
PT rev (3m)21.74%
EPS NQ rev (1m)20%
EPS NQ rev (3m)-55.83%
EPS NY rev (1m)0.17%
EPS NY rev (3m)-1.59%
Revenue NQ rev (1m)6.51%
Revenue NQ rev (3m)0.98%
Revenue NY rev (1m)0.44%
Revenue NY rev (3m)1.31%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.29
P/FCF N/A
P/OCF N/A
P/B 1.7
P/tB 1.7
EV/EBITDA N/A
EPS(TTM)-2.51
EYN/A
EPS(NY)-0.65
Fwd EYN/A
FCF(TTM)-2.29
FCFYN/A
OCF(TTM)-1.04
OCFYN/A
SpS86.92
BVpS14.96
TBVpS14.96
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.45%
ROE -19.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.3%
FCFM N/A
ROA(3y)7.21%
ROA(5y)6.02%
ROE(3y)27.13%
ROE(5y)21.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.42%
GM growth 5Y0.01%
F-Score3
Asset Turnover1.62
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 56.89%
Cap/Sales 1.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.15
Quick Ratio 0.35
Altman-Z 2.72
F-Score3
WACC10.27%
ROIC/WACCN/A
Cap/Depr(3y)110.72%
Cap/Depr(5y)110.21%
Cap/Sales(3y)2.6%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-153.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-39.29%
EPS Next Y-127.33%
EPS Next 2Y22.23%
EPS Next 3Y29.39%
EPS Next 5Y36.3%
Revenue 1Y (TTM)1.99%
Revenue growth 3Y-1.53%
Revenue growth 5Y-0.57%
Sales Q2Q%-0.25%
Revenue Next Year0.33%
Revenue Next 2Y2.03%
Revenue Next 3Y2.86%
Revenue Next 5Y4.63%
EBIT growth 1Y-115.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-1.62%
EBIT Next 3Y49.61%
EBIT Next 5Y42.67%
FCF growth 1Y37.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-144.78%
OCF growth 3YN/A
OCF growth 5YN/A